A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Science

• Publication date

  2001-12-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1066285PMID 11739957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

  2001cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.

  2001cited by this paper
• The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.

  2001cited by this paper
• Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity*

  2001cited by this paper
• The hormone resistin links obesity to diabetes

  2001cited by this paper
• Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

  2001cited by this paper
• Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.

  2001cited by this paper
• Tissue-specific dysregulation of cortisol metabolism in human obesity.

  2001cited by this paper
• Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice.

  2000cited by this paper
• Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase.

  2000cited by this paper
• Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

  2000cited by this paper
• Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice.

  2000cited by this paper
• Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.

  2000cited by this paper
• The perils of portliness: causes and consequences of visceral adiposity.

  2000cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Minireview: 11�-Hydroxysteroid Dehydrogenase Type 1— A Tissue-Specific Amplifier of Glucocorticoid Action*

  2000cited by this paper
• Understanding the Role of Glucocorticoids in Obesity: Tissue-Specific Alterations of Corticosterone Metabolism in Obese Zucker Rats1.

  2000cited by this paper
• Obesity as a medical problem

  2000cited by this paper
• Obesity and cortisol.

  2000cited by this paper
• Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes.

  1999cited by this paper
• Leptin I

  1999cited by this paper
• RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone.

  1999cited by this paper
• The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice.

  1999cited by this paper
• Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system.

  1998cited by this paper
• 11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated.

  1998cited by this paper
• Concentration of sex steroids in adipose tissue after menopause.

  1998cited by this paper
• Obesity and gender influence cortisol secretion and metabolism in man.

  1998cited by this paper
• 11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

  1997cited by this paper
• Does central obesity reflect "Cushing's disease of the omentum"?

  1997cited by this paper
• Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells.

  1997cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.

  1997cited by this paper
• Role of leptin in the neuroendocrine response to fasting

  1996cited by this paper
• A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*)

  1995cited by this paper
• Corticosterone decreases nonshivering thermogenesis and increases lipid storage in brown adipose tissue.

  1995cited by this paper
• Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity.

  1993cited by this paper
• Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase.

  1989cited by this paper
• A rapid, sensitive method for the simultaneous quantitation of estradiol and estradiol conjugates in a variety of tissues: assay development and evaluation of the distribution of a brain-enhanced estradiol-chemical delivery system.

  1989cited by this paper
• Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus.

  1989cited by this paper
• The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease.

  1956cited by this paper

• Metabolic dysregulation: Its role in diabetes mellitus and cancers.

  2026cites this paper
• Sex Hormones–Gut Microbiome Axis: An Update of What Is Known So Far

  2025cites this paper
• Cortisol as a factor contributing to the development of non-alcoholic fatty liver disease in severely obese patients: a single-center prospective study

  2025cites this paper
• Alterations in glucocorticoid homeostasis following sleeve gastrectomy

  2025cites this paper
• Plasma Steroid Profiles in Individuals With Class II/III Obesity: Association With Weight Loss After Metabolic Surgery

  2025cites this paper
• 11β-HSD1 inhibitor alleviates lipid metabolism disorder by activating the AMPK signaling pathway

  2025cites this paper
• Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

  2025cites this paper
• High-carbohydrate diet-induced central obesity in gerbils: 20-hydroxyecdysone effects on adrenal zona fasciculata histology

  2025cites this paper
• Vital Role of Visceral Adipose Tissue in Maintaining Cognitive Functions

  2025cites this paper
• Endocrine consequences of childhood obesity: a narrative review

  2025cites this paper
• Bmal1 deficiency in neutrophils alleviates symptoms induced by high-fat diet

  2025cites this paper
• New Insights into Chemical Profiles and Health-Promoting Effects of Edible Mushroom Dictyophora indusiate (Vent ex. Pers.) Fischer: A Review

  2025cites this paper
• Recent Advances in the Biological Activities of Monocarbonyl Curcumin Analogues (MACs)

  2025cites this paper
• Enantioselective Synthesis of α-Aryl-α-fluoroketones by CPA-Catalyzed Desymmetrization of 1,3-Indanediones.

  2025cites this paper
• Adipose chemokine ligand CX3CL1 contributes to maintaining the hippocampal BDNF level, and the effect is attenuated in advanced age

  2025cites this paper
• Glucocorticoid metabolism: A scientific lifetime in and beyond psychoneuroendocrinology.

  2025cites this paper
• Computational QSAR study of novel 2-aminothiazol-4(5H)-one derivatives as 11β‐HSD1 inhibitors

  2025cites this paper
• Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders

  2025cites this paper
• Neuro-immune Interactions in Metabolic Regulation: Brain and Adipose Tissue Crosstalk

  2025cites this paper
• Effects of glucocorticoids on adipose tissue plasticity.

  2024cites this paper
• Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity

  2024cites this paper
• Current Challenges and Future Directions in the Assessment of Glucocorticoid Status

  2024cites this paper
• High-fat diet-induced increase in glucocorticoids contributes to adipogenesis in obese mice

  2024cites this paper
• Impaired 11β-HSD1 Activity in a Male Patient With Cushing Disease Resulting in Lack of the Full Cushingoid Phenotype

  2024cites this paper
• A hamster model for stress-induced weight gain.

  2024cites this paper
• JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production.

  2024cites this paper
• Corticotropin‐releasing hormone and obesity: From fetal life to adulthood

  2024cites this paper
• Cinnamon (Cinnamomum zeylanicum) Aqueous Extract Regulates the Parameters of Metabolic Syndrome in a Model of Wistar Rats with a Diet High in Fat and Fructose

  2024cites this paper
• Association of seasonal changes in circulating cortisol concentrations with the expression of cortisol biosynthetic enzymes and a glucocorticoid receptor in the blubber of common bottlenose dolphin.

  2024cites this paper
• Steroid and bioactive molecule conjugates: Improving therapeutic approaches in disease management

  2024cites this paper
• Green synthesis and physical characterization of zinc oxide nanoparticles (ZnO NPs) derived from the methanol extract of Euphorbia dracunculoides Lam. (Euphorbiaceae) with enhanced biosafe applications

  2024cites this paper
• Deciphering the role of alternative splicing as a potential regulator in fat-tail development of sheep: a comprehensive RNA-seq based study

  2024cites this paper
• Genetic effects of sequence-conserved enhancer-like elements on human complex traits

  2024cites this paper
• Dexamethasone-Induced Insulin Resistance Attenuation by Oral Sulfur–Oxidovanadium(IV) Complex Treatment in Mice

  2024cites this paper
• Network Pharmacology and Molecular Docking Validation to Explore the Pharmacological Mechanism of Zhuling Decoction against Nephrotic Syndrome.

  2024cites this paper
• Regulation of lipid droplet dynamics and lipid homeostasis by hydroxysteroid dehydrogenase proteins.

  2024cites this paper
• Integrating network pharmacology and animal experimental validation to investigate the action mechanism of oleanolic acid in obesity

  2024cites this paper
• Western diet exacerbates a murine model of Balkan nephropathy.

  2024cites this paper
• Porcine transient receptor potential channel 1 promotes adipogenesis and lipid deposition

  2024cites this paper
• Adipose tissue in cortisol excess: What Cushing's syndrome can teach us?

  2024cites this paper
• Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Endocrine disorders associated with obesity.

  2023cites this paper
• The Mechanism of Kelulut Honey in Reversing Metabolic Changes in Rats Fed with High-Carbohydrate High-Fat Diet

  2023cites this paper
• Structural homology between 11 beta-hydroxysteroid dehydrogenase and Mycobacterium tuberculosis Inh-A enzyme: Dehydroepiandrosterone as a potential co-adjuvant treatment in diabetes-tuberculosis comorbidity

  2023cites this paper
• An 11-Beta Hydroxysteroid Dehydrogenase Type 1 Inhibitor, JTT-654 Ameliorates Insulin Resistance and Non-obese Type 2 Diabetes.

  2023cites this paper
• Time- and glucose-dependent differentiation of 3T3-L1 adipocytes mimics dysfunctional adiposity.

  2023cites this paper
• Visceral fat sympathectomy ameliorates systemic and local stress response related to chronic sleep restriction

  2023cites this paper
• Sensitivity of the Neuroendocrine Stress Axis in Metabolic Diseases

  2023cites this paper
• In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 1 activity.

  2023cites this paper
• Glucocorticoid signaling and the impact of high-fat diet on adipogenesis in vivo

  2023cites this paper
• Comprehensive assessment of cortisol and cortisol metabolites provides insight into the complex relationship between HPA axis function and BMI

  2023cites this paper
• 11β‐Hydroxysteroid dehydrogenase and the brain: Not (yet) lost in translation

  2023cites this paper
• The Association of CUZD1 and STAT5 in Adipocytes

  2023influential citation
• Assessment of steroid enzymes action in children and adolescents with obesity.

  2023cites this paper
• Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess

  2023cites this paper
• Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges

  2023cites this paper
• Effects of very low-calorie ketogenic diet on hypothalamic–pituitary–adrenal axis and renin–angiotensin–aldosterone system

  2023cites this paper
• The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Glucocorticoids contribute to metabolic and liver impairments induced by lactation overnutrition in male adult rats

  2023cites this paper
• Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism.

  2023cites this paper
• Transcriptional repression of beige fat innervation via a YAP/TAZ-S100B axis

  2023cites this paper
• Adipose tissue as a cause of endocrine dysfunction.

  2023cites this paper
• Genetic effects of sequence-conserved enhancer-like elements on human complex traits

  2022influential citation
• 11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases

  2022cites this paper
• New Insights into the Role of Insulin and Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Metabolic Syndrome

  2022cites this paper
• Saroglitazar ameliorates monosodium glutamate-induced obesity and associated inflammation in Wistar rats: Plausible role of NLRP3 inflammasome and NF- κB

  2022cites this paper
• Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach.

  2022cites this paper
• Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions

  2022cites this paper
• Early life stress exacerbates obesity in adult female mice via mineralocorticoid receptor-dependent increases in adipocyte triglyceride and glycerol content.

  2022cites this paper
• Discovery of a novel 2-spiro-proline steroid mimetic scaffold for the potent inhibition of 11β-HSD1.

  2022cites this paper
• Obesity I: Overview and molecular and biochemical mechanisms.

  2022cites this paper
• Tissue-Specific Regulation of 11β Hydroxysteroid Dehydrogenase Type-1 mRNA Expressions in Cushing's Syndrome Mouse Model.

  2022cites this paper
• Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside

  2022cites this paper
• Development and structure–activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors

  2022cites this paper
• Contribution of neuroinflammation, resolution, and neuroprotection in neuropsychiatric diseases

  2022cites this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases

  2022influential citation
• Animal models of Cushing's syndrome.

  2022cites this paper
• The History of Obesity Research

  2022cites this paper
• Vertical sleeve gastrectomy normalizes circulating glucocorticoid levels and lowers glucocorticoid action tissue-selectively in mice

  2022cites this paper
• The GR-gp78 Pathway is involved in Hepatic Lipid Accumulation Induced by Overexpression of 11β-HSD1

  2022cites this paper
• Inhibition of 11 β -HSD1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis

  2021cites this paper
• The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction

  2021cites this paper
• Sex steroids and adiposity in a prospective observational cohort of youth

  2021cites this paper
• Selective Inhibition of 11 β -Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice

  2021cites this paper
• 5-Bis-(2,6-difluoro-benzylidene) Cyclopentanone Acts as a Selective 11β-Hydroxysteroid Dehydrogenase one Inhibitor to Treat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice

  2021cites this paper
• Carbonyl reductase 1 amplifies glucocorticoid action in adipose tissue and impairs glucose tolerance in lean mice

  2021cites this paper
• Negative associations of morning serum cortisol levels with obesity: the Henan rural cohort study

  2021cites this paper
• 16α‐Bromoepiandrosterone as a new candidate for experimental diabetes–tuberculosis co‐morbidity treatment

  2021cites this paper
• Exploring the Cell Stemness and the Complexity of the Adipose Tissue Niche

  2021cites this paper
• Visceral adiposity, inflammation, and hippocampal function in obesity.

  2021cites this paper
• High‐fat diet‐induced increases in glucocorticoids contribute to the development of non‐alcoholic fatty liver disease in mice

  2021cites this paper
• Network pharmacology analysis of pharmacological mechanisms underlying the anti-type 2 diabetes mellitus effect of guava leaf

  2021cites this paper
• Possible Involvement of Adipose Tissue in Older and Obese Diabetic Patients with Coronavirus SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19

  2021cites this paper
• The drug discovery process: From ancient times to the present day

  2021cites this paper
• Structure-based molecular modeling in SAR analysis and lead optimization

  2021cites this paper
• Identifying dietary pattern associated with adiposity among Malaysian young adults

  2021cites this paper
• Mifepristone improves adipose tissue insulin sensitivity in insulin resistant individuals.

  2021cites this paper
• Steroid Metabolism in Children and Adolescents With Obesity and Insulin Resistance: Altered SRD5A and 20α/20βHSD Activity

  2021cites this paper
• New Targets for Drug Therapy in Type 2 Diabetes Mellitus

  2021cites this paper
• Brain-Restricted Inhibition of IL-6 Trans-Signaling Mildly Affects Metabolic Consequences of Maternal Obesity in Male Offspring

  2021cites this paper